Douglas Robert Andrew
- SEC CIK
- 0001352232
No open-market purchases or sales filed in the past year.
Current role at each company
- GMED Globus Medical IncDirectoras of Jan 23, 2026
- RMD Resmed IncSpecial Advisoras of Jan 3, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Douglas Robert Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RMD Resmed Inc
Special Advisor22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 (view filing) | Aug 15 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −1.50K | $181.01 | −$271.5K | −0.6%250.5K after | 10b5-1 |
| Jul 18, 2023 (view filing) | Jul 17 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −1.50K | $222.22 | −$333.3K | −0.6%252.0K after | 10b5-1 |
| Jun 20, 2023 (view filing) | Jun 15 | 5 days | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −1.50K | $216.27 | −$324.4K | −0.6%253.5K after | 10b5-1 |
| May 16, 2023 (view filing) | May 15 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −1.50K | $232.85 | −$349.3K | −0.6%255.0K after | 10b5-1 |
| Apr 18, 2023 (view filing) | Apr 17 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −1.50K | $224.65 | −$337.0K | −0.6%256.5K after | 10b5-1 |
| Mar 16, 2023 (view filing) | Mar 15 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −1.50K | $206.14 | −$309.2K | −0.6%258.0K after | |
| Feb 16, 2023 (view filing) | Feb 15 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −1.50K | $213.50 | −$320.3K | −0.6%261.4K after | |
| Jan 18, 2023 (view filing) | Jan 17 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −1.50K | $220.43 | −$330.6K | −0.7%226.2K after | |
| Nov 16, 2022 (view filing) | Nov 15 | 1 day | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −11.3K | $222.07 | −$2.50M | −21.9%40.2K after | |
| Oct 17, 2022 (view filing) | Oct 14 | 3 days | Douglas Robert AndrewPresident and COO | SSaleResMed Common Stock | −11.4K | $215.09 | −$2.44M | −24.5%35.1K after |